Results 261 to 270 of about 32,738 (290)

Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial

Journal of Surgical Oncology, 2021
The PERISCOPE I (Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyPErthermic intraperitoneal chemotherapy) study was conducted to investigate the safety and feasibility of hyperthermic intraperitoneal ...
W. Koemans, R. T. van der Kaaij, E. Wassenaar, D. Boerma, H. Boot, K. Sikorska, M. Los, C. Grootscholten, K. Hartemink, A. Veenhof, Liudmila L. Kodach, P. Snaebjornsson, J. V. van Sandick   +12 more
semanticscholar   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review

Diseases of the Colon & Rectum, 2021
BACKGROUND: Combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is emerging as an alternative option for colorectal peritoneal metastases, but there is ambiguity regarding patient selection, treatment ...
Manasi Parikh, Paul Johnson, J. Romanes, H. Freitag, M. Spring, N. Garcia-Henriquez, J. Monson   +6 more
semanticscholar   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer

Journal of Obstetrics and Gynaecology Research, 2020
AbstractAimHyperthermic intraperitoneal chemotherapy (HIPEC) is a method of administering anticancer agents directly while heating the abdominal cavity. The aim of this review is to know the current position of HIPEC in ovarian cancer and uterine sarcoma and its future prospects.MethodsThis article reviews the current literature and evidence for the ...
Hideaki, Tsuyoshi, Daisuke, Inoue, Tetsuji, Kurokawa, Yoshio, Yoshida   +3 more
openaire   +2 more sources

Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25‐year experience

Journal of Surgical Oncology, 2021
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is predominantly performed and studied in academic centers. While developing CRS/HIPEC programs in nonacademic hospitals can increase accessibility, its safety and ...
A. Nikiforchin, V. Gushchin, M. King, E. Baron, C. Nieroda, M. Sittig, A. Sardi   +6 more
semanticscholar   +1 more source

Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis

Diseases of the Colon & Rectum, 2021
Supplemental Digital Content is available in the text. BACKGROUND: Synchronous liver resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases have traditionally been contraindicated ...
M. Flood, Atandrila Das, Mikael L Soucisse, Joseph C. H. Kong, R. Ramsay, M. Michael, B. Loveday, S. Warrier, A. Heriot   +8 more
semanticscholar   +1 more source

Scrotal Ulcer After Intraperitoneal Hyperthermic Chemotherapy

Urology, 2007
Tumor cytoreduction combined with intraperitoneal hyperthermic chemotherapy has been shown to be an effective method to delay the progression of peritoneal carcinomatosis. We describe 2 cases of painful scrotal ulcer after tumor debulking and intraperitoneal infusion of mitomycin-C for treatment of metastatic abdominal malignancies.
Ardavan, Akhavan, Ming, Yin, Ronald, Benoit   +2 more
openaire   +2 more sources

Laparoscopic hyperthermic intraperitoneal chemotherapy for appendiceal tumors

Asian Journal of Endoscopic Surgery, 2020
AbstractIntroductionThe application of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal and appendix cancer at risk of peritoneal seeding is an appealing strategy to prevent peritoneal metastases. Here, we present the technical details and postoperative outcomes of laparoscopic HIPEC performed with prophylactic intent in three patients ...
Antonio Sommariva, Marco Tonello, Ottavia De Simoni, Andrea Barina, Carlo Riccardo Rossi, Pierluigi Pilati   +5 more
openaire   +2 more sources

[Hyperthermic intraperitoneal chemotherapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2019
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are recognized as the standard of care for selected patients with peritoneal malignancies. A complete macroscopic cytoreduction is the basis for a successful multimodal treatment. The significance of intraperitoneal chemotherapy is still under discussion.
H, Leebmann, P, Piso
openaire   +1 more source

Intraperitoneal hyperthermic chemotherapy in ovarian cancer

International Journal of Gynecological Cancer, 2005
We investigated the effect of intraperitoneal hyperthermic perfusion chemotherapy as consolidation therapy in stage IIIB-IIIC ovarian cancer, following cytoreductive surgery and systemic chemotherapy (cisplatin-cyclophosphamide--six cycles). Disease-free survival, overall survival, and side effects were compared with a control group of patients who ...
J, Gori, R, Castaño, M, Toziano, D, Häbich, J, Staringer, D G B, De Quirós, N, Felci   +6 more
openaire   +2 more sources

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update

Hormone Molecular Biology and Clinical Investigation, 2020
Abstract In the treatment of advanced-stage epithelial ovarian cancer (EOC)-associated surgery and chemotherapy with intravenous platinum/taxane-based therapy most patients had early or late recurrence. Prevention of progression and recurrence is a major objective for the management of EOC.
Revaux, A., Carbonnel, M., Kanso, F., Naoura, I., Asmar, J., Kadhel, P., Ayoubi, J.-M.   +6 more
openaire   +3 more sources